Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-14

Clinical Trial Update: Safety and Acceptability of Carraguard® in HIV Positive Women and Men [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and acceptability of Carraguard, a carrageenan-based vaginal microbicide, in HIV-positive men and women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carraguard

Snippet

Sponsor: Population Council | Conditions: HIV Infections | Phase 1 | Status: COMPLETED